RavenQuest BioMed Inc.
RVVQF
$0.00
$0.000.00%
| 07/31/2019 | 04/30/2019 | 01/31/2019 | 10/31/2018 | 07/31/2018 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 1.19M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 1.19M |
| Cost of Revenue | -- | -- | -- | -- | 403.10K |
| Gross Profit | -- | -- | -- | -- | 784.30K |
| SG&A Expenses | -- | -- | -- | -- | 6.02M |
| Depreciation & Amortization | -- | -- | -- | -- | 32.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | -- | 6.52M |
| Operating Income | -- | -- | -- | -- | -5.33M |
| Income Before Tax | -- | -- | -- | -- | -8.23M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -- | -- | -- | -8.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | 100.00 |
| Net Income | -- | -- | -- | -- | -8.23M |
| EBIT | -- | -- | -- | -- | -5.33M |
| EBITDA | -- | -- | -- | -- | -5.30M |
| EPS Basic | -- | -- | -- | -- | -0.12 |
| Normalized Basic EPS | -- | -- | -- | -- | -0.05 |
| EPS Diluted | -- | -- | -- | -- | -0.12 |
| Normalized Diluted EPS | -- | -- | -- | -- | -0.05 |
| Average Basic Shares Outstanding | -- | -- | -- | -- | 297.78M |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | 297.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
